Fas and the art of lymphocyte maintenance.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

55 citing papers in PubMed.

1. Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant.Clinical cancer research : an official journal of the American Association for Cancer Research · 2008
   Trial
2. Membrane-Based Assembly and Interactions in Immune Receptors.Chemical reviews · 2026
   Review
3. Local delivery of IL-15 and anti-PD-L1 nanobody by in vitro-transcribed circILNb elicits superior antitumor immunity in cold tumors.Cell reports. Medicine · 2025
   Article
4. Rigid crosslinking of the CD3 complex leads to superior T cell stimulation.Frontiers in immunology · 2024
   Article
5. Research progress of interleukin-15 in cancer immunotherapy.Frontiers in pharmacology · 2023
   Review
6. An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery.The Journal of experimental medicine · 2022
   Article
7. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.Biomedical journal · 2021
   Review
8. Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy.Cancers · 2020
   Review
9. Cytokines in the Treatment of Cancer.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2019
   Review
10. Cytokines in Cancer Immunotherapy.Cold Spring Harbor perspectives in biology · 2018
    Review
11. Six novel susceptibility loci for coronary artery disease and cerebral infarction identified by longitudinal exome-wide association studies in a Japanese population.Biomedical reports · 2018
    Article
12. Dynamic demethylation of the IL2RA promoter during in vitro CD4+ T cell activation in association with IL2RA expression.Epigenetics · 2018
    Article
13. Autoimmune lymphoproliferative syndrome: more than a FAScinating disease.F1000Research · 2017
    Review
14. The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy.Cancer immunology research · 2015
    Review
15. Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2015
    Article
16. Interleukin-15 in the treatment of cancer.Expert review of clinical immunology · 2014
    Review
17. AKT family and miRNAs expression in IL-2 induced CD4(+)T cells.Iranian journal of basic medical sciences · 2014
    Article
18. Functions of IL-15 in anti-viral immunity: multiplicity and variety.Cytokine · 2012
    Review
19. The potential of Fas ligand (apoptosis-inducing molecule) as an unconventional therapeutic target in type 1 diabetes.Frontiers in immunology · 2012
    Article
20. How I treat autoimmune lymphoproliferative syndrome.Blood · 2011
    Review

Corrections and comments

• Comment on
  Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia.1996

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as